Genomic Diagnostics Co. Veracyte Announces Q2 Financial Results
Total Revenue Increased 166% to $55.1 million; Genomic Volume Grew 215% to 20,856 Tests
Company Advanced Clinical Evidence, Pipeline and Global Growth Strategy
Raises 2021 Total Revenue Guidance
Conference Call and Webcast Today at 4:30 p.m. ET
Veracyte, Inc. (Nasdaq:…
Genomic Vision: First-half 2021 Results
Genomic Vision: First-half 2021 Results
H1 2021 sales impacted by the Covid-19 crisis (-24.6% to €467 thousand) Encouraging upturn in activity in Q2, with sales...
Deep Genomics Raises $180M in Series C Financing
Deep Genomics Raises $180M in Series C Financing
Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic Oversubscribed round...
Vizgen, Spatial Genomics Innovator, Expands Leadership Team
Vizgen, Spatial Genomics Innovator, Expands Leadership Team
Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization Vizgen, the...
Element Biosciences Boosts Leadership for DNA Sequencing Platform
Element Biosciences Boosts Leadership for DNA Sequencing Platform
Brian Stolz Joins as Chief People Officer, Diana King as VP of Customer Support, and Jordan Neysmith as VP of...